Journal of Natural Remedies

K. Samraj ¹, K. Nandhagopal ¹, S. Radha ¹, S. Rajalakshmi ¹, K. Arunachalam ¹, K. Kanakavalli ²

Affiliations
1 Siddha Clinical Research Unit, Central Council for Research in Siddha, Tirupati – 517507, Andhra Pradesh, IN
2 Central Council for Research in Siddha, Chennai – 600106, Tamil Nadu, IN

Abstract

Siddha Clinical Research Unit (SCRU) Tirupati, working under the Central Council for Research in Siddha (CCRS), Ministry of AYUSH, Govt. of India, conducted a National Web conference titled “Integrated Siddha Approach in Clinical Practice and Research on COVID-19 Pandemic (ISACC)” on 23^rd Dec 2020, as a part of the fourth Pre-Siddha Day observance. Totally, 256 participants from Siddha colleges and various institutes of CCRS attended the Web conference and 9 eminent Speakers share their knowledge at the conference. The Technical session was separated by three panels, (i)Siddha Standalone and Integrative Clinical trials on COVID-19, (ii)Siddha Preventive and Prophylactic Measures on COVID-19, (iii)Experiences in Siddha Integrative Clinical Practice on COVID-19. The take home message of the conference insisted upon the three facts - the need for more clinical trials , need for increased experience sharing platforms for Siddha medical system and finally that Siddha standalone as well as integration for COVID-19 management gave significant outcome in both preventive and promotive healthcare. Central Council for Research in Siddha (CCRS), Ministry of AYUSH, Govt. of India and Directorate of Indian Medicine and Homeopathy (DIM&H), Government of Tamil Nadu, contributed a lot in Research and services in COVID-19 pandemic.

Keywords

Siddha Medicine, Integrative Medicine, COVID-19, CCRS, 4^th Siddha Day

Full Text

   

S. Radha ¹, S. P. Rajalakshmi ², K. Subash ³, K. Samraj ¹

Affiliations
1 Siddha Clinical Research Unit, Tirupati – 517507, Andhra Pradesh, IN
2 Santhigiri Siddha Medical College, Thiruvananthapuram – 695589, Kerala, IN
3 Sri Padmavathi Medical College for Women, Tirupati – 517507, Andhra Pradesh, IN

Abstract

Respiratory Tract Infections (RTIs) are the most common, and potentially most severe, of infections treated by health care practitioners. Lower RTIs along with influenza, are the most common cause of death by infection. The fatality risk is doubled if the person is with other morbid conditions or in extremes of age. These seasonal respiratory infections caused by viruses are of more concern as their spread is very vast than we imagine. COVID-19 (corona virus disease 2019) is such a pandemic respiratory illness caused by severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), a strain of Corona virus. The emerging anti-microbial resistance and easy spread of respiratory pathogens has also increased the challenge for appropriate management of RTI like COVID-19. Drugs with anti-viral property and potency to prevent the comorbidity stand are the need of the hour. This review article includes information on preclinical studies and clinical studies to add a scientific validation to formulations that are commonly used in Siddha system of Medicine. The ingredients of the Siddha drugs possessing anti-viral property and immune-modulatory effect particularly against respiratory pathogens are elaborated. Evidence of anti-viral property has been made out to the light for further clinical trials.

Keywords

Antiviral Drug, Immuno-modulator, Influenza, Respiratory Tract Infection, Siddha Medicine, COVID-19

Full Text